Rock Tech Engages Northern Bioscience for Environmental Assessment Baseline Studies

Vancouver, BC, Canada – July 8, 2019 Rock Tech Lithium Inc. (the “Company” or “Rock Tech”) (TSX-V: RCK; Frankfurt: RJIB) is pleased to announce that it has engaged Northern Bioscience Ecological Consulting (“Northern Bioscience”) to complete baseline studies supporting an Environmental Assessment at the Company’s 100%-owned Georgia Lake lithium project in Ontario, Canada.

The baseline studies will focus on the preliminary project site, transmission line and adjacent lakes and streams covering 652 hectares and the Nama Creek access road to Provincial Highway 11. The scope of the baseline studies will include fish and aquatic habitat, benthic macroinvertebrates, sediment samples, breeding birds, terrestrial vegetation, Woodland caribou, species at risk, migratory birds and significant wildlife habitat.

Rock Tech’s chairman leads planning session with field crew at the Georgia Lake lithium project.

 

“As we advance through the environmental permitting process it’s essential to have the expertise of locals onboard,” said Dirk Harbecke, Rock Tech’s chairman. “Having the City of Thunder Bay, a world-class mining hub, located just a short drive from site is a big comparative advantage for Rock Tech as we develop our Georgia Lake lithium project.”

All scientific and technical information in this news release concerning the Georgia Lake lithium property was reviewed and approved by Karl-Stephan Peters, EurGeol 787, a qualified person (QP) as defined under National Instrument 43-101.“As we advance through the environmental permitting process it’s essential to have the expertise of locals onboard,” said Dirk Harbecke, Rock Tech’s chairman. “Having the City of Thunder Bay, a world-class mining hub, located just a short drive from site is a big comparative advantage for Rock Tech as we develop our Georgia Lake lithium project.”

About Northern Bioscience Ecological Consulting

Northern Bioscience offers professional consulting services supporting ecosystem management, inventory, and research. Based in Thunder Bay, Northern Bioscience was established in 1996 and has undertaken over 400 projects for government, industry, First Nations, non-government organizations (NGOs), and landowners. They have carried out projects in six provinces and two territories in Canada, as well as in the United States.

Northern Bioscience’s principals combine strong academic backgrounds and experience working for government with an extensive network of highly experienced professional associates. They are among the leaders in understanding the boreal flora, fauna, and ecosystems in northern Ontario. Since they are a small company, personal attention of the principals is ensured from field work through to reporting. With low overhead and efficient project teams, they deliver realistic work plans and budgets with cost-effective solutions. Northern Bioscience can assemble a multi-disciplinary team of environmental professionals to provide a full range of ecological services.

On behalf of the Board of Directors of the Company,

“Martin Stephan”
Martin Stephan
Director, Chief Executive Officer

For further information, please contact:

Brad Barnett: bbarnett@rocktechlithium.com
Chief Financial Officer
Telephone: (778) 358-5200

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as, “forward‐looking statements”.  Forward‐looking statements may be identified by words including “anticipates”, “believes”, “intends”, “estimates”, “expects” and similar expressions.  The Company cautions readers that forward‐looking statements, including without limitation those relating to the Company’s future operations and business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward‐looking statements.